NCT07281690 is a Phase 3 clinical trial of 1064-nm Nd:YAG Laser Treatment in Laser Therapy, sponsored by Laser Beamer Skincare.

Who is sponsoring NCT07281690?

NCT07281690 is sponsored by Laser Beamer Skincare.

What drugs are being tested in NCT07281690?

Interventions in NCT07281690: 1064-nm Nd:YAG Laser Treatment, Topical Umbilical Cord-Derived Exosomes (UC-MSC Exosomes).

What condition does NCT07281690 study?

NCT07281690 studies Laser Therapy, Exosomes.

Is NCT07281690 still recruiting?

NCT07281690 is currently completed. Last updated 15 December 2025.

Last reviewed 2025-12-15 · How we verify

NCT07281690

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Enhancing Skin Rejuvenation Using Laser and Exosomes

Completed Phase 3 Last updated 15 December 2025

What this trial tests

Phase 3 trial testing 1064-nm Nd:YAG Laser Treatment in Laser Therapy in 20 participants. Completed in 17 July 2025.

Timeline

1 March 2025

Primary endpoint
17 July 2025

17 July 2025

Quick facts

Lead sponsor	Laser Beamer Skincare
Phase	Phase 3
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	20
Start date	1 March 2025
Primary completion	17 July 2025
Estimated completion	17 July 2025
Sites	1 location across United States

Drugs / interventions tested

1064-nm Nd:YAG Laser Treatment
Topical Umbilical Cord-Derived Exosomes (UC-MSC Exosomes) — full drug profile →

Conditions studied

Laser Therapy — all drugs for Laser Therapy →
Exosomes — all drugs for Exosomes →

Sponsor

Laser Beamer Skincare — full company profile →

Who can join

Adults 45 to 70, female only, with Laser Therapy or Exosomes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Enhancing Skin Rejuvenation A Single-Blind, Randomized Control Study on the Combined Efficacy of Aerolase 1064 nm YAG Laser and Exosomes Derived from Umbilical Cord Mesenchymal Stem Cells

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The global clinical landscape of human-derived extracellular vesicles: an analysis based on ClinicalTrials.gov (2010-2025).
Wei W, Wu X, Wang L, Yu Y, et al · · 2026 · PMID 41874702 · DOI 10.1007/s10238-026-02124-4

Verify or expand the search:

Other recruiting trials for Laser Therapy

Currently open trials in the same condition.

NCT07023952 — Effect of Phenol Addition to Laser Treatment on Epithelialization and Healing Process in Pilonidal Sinus · NA · recruiting
NCT06423495 — Efficacy of Photobiomodulation in the Rehabilitation of Olfactory Dysfunctions Induced by Long COVID-19 · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07281690 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Laser Beamer Skincare
Last refreshed: 15 December 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07281690.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing